All Webcasts > When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden?
When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden? Guidelines based on Delphi Consensus
A Delphi Consensus was created to establish guidelines on fluorescence imaging of bacterial burden (MolecuLight i:X), the only point-of-care solution to visualize the presence of significant bacterial burden (>104 CFU/g) in wounds.
Join 5 of the authors of the Delphi Consensus as they discuss:
- Clinical indications for fluorescence imaging (e.g., delayed wound healing, before and after debridement, before placement of cellular and tissue-based products)
- Recommended frequency of fluorescence imaging
- Real-world impact of fluorescence imaging on clinical decision making and associated wound outcomes
Fluorescence Imaging Guidelines
Videos Recommended for You
Utility of Point-of-Care Fluorescence for Detection of Elevated Bacterial Burden in an Outpatient Wound Care Setting
Bacterial Burden
Adopting Fluorescence Imaging for Detection of Elevated Bacterial Burdenas a Standard of Care in our Long-Term Care Facilities
Long Term Care Application
Learn more about our new Reimbursement Pathway
If you’d like to learn how the MolecuLight i:X can help your practice, you can book a demonstration here.
Check out our upcoming Webinars and Events
